From 2005 to 2015, depression rose significantly among Americans age 12 and older, according to researchers at the Mailman School of Public Health and CUNY.
The short-term suicide risk in patients discharged from psychiatric hospitals is greatest for patients with depression, finds a study from Columbia Psychiatry.
The antidepressant fluoxetine decreases bone density, but a new CUMC study suggests adding a beta-blocker to treatment can prevent the loss of bone.
An international observational study led by Columbia University researchers has uncovered widespread differences in the treatment of patients with common chronic diseases, including type 2 diabetes, hypertension, and depression.
Use of selective serotonin reuptake inhibitors (SSRIs) during pregnancy is associated with an increased rate of offspring depression, a new study has found.
Increased connectivity in the brain's default mode network is a potential precursor, or biomarker, indicating a risk of developing major depressive disorder.